πŸ‡ΊπŸ‡Έ FDA
Patent

US 11344610

Prevention and reduction of blood loss

granted A61KA61K38/55A61K38/57

Quick answer

US patent 11344610 (Prevention and reduction of blood loss) held by Takeda Pharmaceutical Company Limited expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/55, A61K38/57, A61K9/0019, A61P